Literature DB >> 17159794

Blood metallothionein, neuron specific enolase, and protein S100B in patients with traumatic brain injury.

Jirí Kukacka1, David Vajtr, Dalibor Huska, Richard Průsa, Ladislav Houstava, Filip Samal, Václav Diopan, Karel Kotaska, René Kizek.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the correlation of neuron specific enolase (NSE), protein S100B and time-profile of Glasgow Coma Score (GCS) development with metallothionein (MT) blood levels in patients with traumatic brain injury (TBI) during 10 days of hospitalization. Patients were divided into 2 groups with respect to NSE and S100B levels - with (group I) and without (group II) GCS improvement.
METHODS: Serum NSE and S100B concentrations were measured by immunochemical methods; serum metallothionein concentration by electrochemical technique. Cortical biopsies were investigated immunohistochemically and by electron microscope. A cDNA microarray containing 700 gene probes was used to study the changes in gene expression in the ipsilateral cortex.
RESULTS: Values of MT in the blood of group I showed a non-significant decrease compared to group II during 1-3 days after admission. There was an increase of MT during 4-8 days in comparison with values of 1-3 days. The highest value of MT during hospitalization was found in a patient with diffuse axonal injury (group II). The data of cDNA microarray suggested an increase in expression of gene transcripts for oxygen free radical scavenger proteins corresponding with the increase of MT during 4-8 days in both groups.
CONCLUSIONS: The experimental data indicate that monitoring the content of MT in patients with trauma brain injury would be a suitable approach to evaluate the degree of injury or duration of prolonging unconsciousness, particularly in diagnosis of diffuse axonal injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159794

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  13 in total

1.  Head injury serum markers for assessing response to trauma: Design of the HeadSMART study.

Authors:  Matthew E Peters; Vani Rao; Kathleen T Bechtold; Durga Roy; Haris I Sair; Jeannie-Marie Leoutsakos; Ramon Diaz-Arrastia; Robert D Stevens; D Scott Batty; Hayley Falk; Christopher Fernandez; Uju Ofoche; Alexandra Vassila; Anna J Hall; Braden Anderson; Edward Bessman; Constantine G Lyketsos; Allen D Everett; Jennifer Van Eyk; Frederick K Korley
Journal:  Brain Inj       Date:  2017-01-31       Impact factor: 2.311

2.  Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.

Authors:  Andrew K Ottens; Liliana Bustamante; Erin C Golden; Changping Yao; Ronald L Hayes; Kevin K W Wang; Frank C Tortella; Jitendra R Dave
Journal:  J Neurotrauma       Date:  2010-10-09       Impact factor: 5.269

3.  Metallothionein treatment attenuates microglial activation and expression of neurotoxic quinolinic acid following traumatic brain injury.

Authors:  R S Chung; Y K Leung; C W Butler; Y Chen; E D Eaton; M W Pankhurst; A K West; G J Guillemin
Journal:  Neurotox Res       Date:  2009-03-20       Impact factor: 3.911

4.  Utilizing of Adsorptive Transfer Stripping Technique Brdicka Reaction for Determination of Metallothioneins Level in Melanoma Cells, Blood Serum and Tissues.

Authors:  Sona Krizkova; Ivo Fabrik; Vojtech Adam; Jiri Kukacka; Richard Prusa; Grace J Chavis; Libuse Trnkova; Jan Strnadel; Vratislav Horak; Rene Kizek
Journal:  Sensors (Basel)       Date:  2008-05-10       Impact factor: 3.576

5.  A Determination of Metallothionein in Larvae of Freshwater Midges (Chironomus riparius) Using Brdicka Reaction.

Authors:  Ivo Fabrik; Zuzana Ruferova; Klara Hilscherova; Vojtech Adam; Libuse Trnkova; Rene Kizek
Journal:  Sensors (Basel)       Date:  2008-07-10       Impact factor: 3.576

6.  Increased circulating leukocyte numbers and altered macrophage phenotype correlate with the altered immune response to brain injury in metallothionein (MT)-I/II null mutant mice.

Authors:  Michael W Pankhurst; William Bennett; Matthew T K Kirkcaldie; Adrian K West; Roger S Chung
Journal:  J Neuroinflammation       Date:  2011-12-07       Impact factor: 8.322

7.  Metallothionein (MT) -I and MT-II expression are induced and cause zinc sequestration in the liver after brain injury.

Authors:  Michael W Pankhurst; David A Gell; Chris W Butler; Matthew T K Kirkcaldie; Adrian K West; Roger S Chung
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

8.  Military personnel with chronic symptoms following blast traumatic brain injury have differential expression of neuronal recovery and epidermal growth factor receptor genes.

Authors:  Morgan Heinzelmann; Swarnalatha Y Reddy; Louis M French; Dan Wang; Hyunhwa Lee; Taura Barr; Tristin Baxter; Vincent Mysliwiec; Jessica Gill
Journal:  Front Neurol       Date:  2014-10-09       Impact factor: 4.003

9.  Analysis of Post-Traumatic Brain Injury Gene Expression Signature Reveals Tubulins, Nfe2l2, Nfkb, Cd44, and S100a4 as Treatment Targets.

Authors:  Anssi Lipponen; Jussi Paananen; Noora Puhakka; Asla Pitkänen
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

10.  Shapes of Differential Pulse Voltammograms and Level of Metallothionein at Different Animal Species.

Authors:  Vojtech Adam; Miroslava Beklova; Jiri Pikula; Jaromir Hubalek; Libuse Trnkova; Rene Kizek
Journal:  Sensors (Basel)       Date:  2007-10-19       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.